A short overview of the company’s business plans and strategies.
A basic introduction to market needs, solution, competitive advantage, management team, and product roadmap.
Presents market and technology trends, business and product strategies, market forecasts and manufacturing scalability.
A market intelligence analysis of macroeconomic and technology trends in the emerging field of genetic cognitive enhancement.
Project plan and budget for demonstrating the neuron-level mechanism of action for a genetic Alzheimer’s symptomatic reliever.
Office hours 9am-5pm M-F
Compares R&D challenges, side effects and learning curves for the company’s technology with three other dementia treatment technology platforms.
Explains scientific methods for relieving Alzheimer’s symptoms and treating dementia and neurological conditions which affect 80 million Americans.
Presents a large body of scientific evidence supporting the company’s methodology, including Alzheimer’s, CRISPR and human brainwave experiments.